Nundina › Kalender entdecken › FDA-PDUFA-Entscheidungstermine-Kalender › PDUFA date: zanzalintinib + atezolizumab (Exelixis)PDUFA date: zanzalintinib + atezolizumab (Exelixis)3. März 2027FDA PDUFA target action date for zanzalintinib + atezolizumab, a NDA from Exelixis. This is the date by which the FDA is due to act on the application; it can be extended or the decision can come earlier.FDA-PDUFA-Entscheidungstermine-KalenderMehr aus diesem Kalender

26. Oktober 2026 - PDUFA date: bepirovirsen (GSK)

29. Oktober 2026 - PDUFA date: ILUMYA (tildrakizumab-asmn) (Sun Pharmaceutical Industries)

30. Oktober 2026 - PDUFA date: INO-3107 (INOVIO Pharmaceuticals)

1. November 2026 - PDUFA date: mitapivat (Agios Pharmaceuticals)

14. November 2026 - PDUFA date: MYQORZO (aficamten) (Cytokinetics)